Literature DB >> 26496446

Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.

Sarah J Atkinson1, Meghan Nolan, Lindsey Klingbeil, Kelli Harmon, Patrick Lahni, Basilia Zingarelli, Hector R Wong.   

Abstract

OBJECTIVE: Inhibition of matrix metalloproteinase-8 improves survival following cecal ligation and puncture in mice, making it a potential therapeutic target. In the current study, we expand our understanding of the role of matrix metalloproteinase-8 in sepsis by using an adoptive transfer approach and alternative sepsis models.
DESIGN: We used three different sepsis models: cecal ligation and puncture, cecal slurry, and intestinal implantation. In our first model, adoptive transfer experiments were followed by cecal ligation and puncture to test the hypothesis that matrix metalloproteinase-8-containing myeloid cells are a critical factor in sepsis following cecal ligation and puncture. Our second model, cecal slurry, used intraperitoneal injections of cecal contents to induce polymicrobial peritonitis without tissue compromise in the recipient. Our third model, intestinal implantation, involved ligating and puncturing a cecum from a donor, and then removing the cecum and placing it into the recipient's peritoneal cavity. Clinically, blood samples were drawn from pediatric patients within 24 hours of meeting criteria for septic shock.
SETTING: Basic science laboratory.
SUBJECTS: Wild type and genetically modified mice.
INTERVENTIONS: Experimental models of sepsis.
MEASUREMENTS AND MAIN RESULTS: In our adoptive transfer experiments, matrix metalloproteinase-8 null mice receiving wild-type marrow had a survival advantage when compared with wild-type mice receiving matrix metalloproteinase-8 null marrow, suggesting that matrix metalloproteinase-8-containing myeloid cells are not a critical factor in sepsis following cecal ligation and puncture. In our cecal slurry model, no survival advantage was seen among matrix metalloproteinase-8 null mice. Our third model, intestinal implantation, found that mice receiving matrix metalloproteinase-8 null intestine had a survival advantage when compared with mice receiving wild-type intestine, regardless of recipient genotype. Clinically, median matrix metalloproteinase-8 serum concentrations were higher in patients with sepsis and primary intestinal pathology than in septic patients without primary intestinal pathology.
CONCLUSIONS: Intestine-derived matrix metalloproteinase-8 is a critical component of septic peritonitis secondary to intestinal compromise.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26496446      PMCID: PMC4792672          DOI: 10.1097/CCM.0000000000001374

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  29 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

3.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

4.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

5.  Validating the genomic signature of pediatric septic shock.

Authors:  Natalie Cvijanovich; Thomas P Shanley; Richard Lin; Geoffrey L Allen; Neal J Thomas; Paul Checchia; Nick Anas; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Hector R Wong
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

6.  Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.

Authors:  James L Wynn; Philip O Scumpia; Matthew J Delano; Kerri A O'Malley; Ricardo Ungaro; Amer Abouhamze; Lyle L Moldawer
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

7.  Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock.

Authors:  Thomas P Shanley; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Allan Doctor; Meena Kalyanaraman; Nancy M Tofil; Scott Penfil; Marie Monaco; Kelli Odoms; Michael Barnes; Bhuvaneswari Sakthivel; Bruce J Aronow; Hector R Wong
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

8.  The pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Shelia Salisbury; Qiang Xiao; Natalie Z Cvijanovich; Mark Hall; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Anita Sen; Jeffrey Nowak; Michael Quasney; Jared W Henricksen; Arun Chopra; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  Crit Care       Date:  2012-10-01       Impact factor: 9.097

9.  Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.

Authors:  Basilia Zingarelli; Giovanna Piraino; Paul W Hake; Michael O'Connor; Alvin Denenberg; Hongkuan Fan; James A Cook
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 5.770

10.  MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia.

Authors:  Adrián González-López; Alina Aguirre; Inés López-Alonso; Laura Amado; Aurora Astudillo; María Soledad Fernández-García; María F Suárez; Estefanía Batalla-Solís; Enrique Colado; Guillermo M Albaiceta
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  9 in total

1.  Role of matrix metalloproteinase-8 as a mediator of injury in intestinal ischemia and reperfusion.

Authors:  Meghan C Daly; Sarah J Atkinson; Brian M Varisco; Lindsey Klingbeil; Paul Hake; Patrick Lahni; Giovanna Piraino; David Wu; Simon P Hogan; Basilia Zingarelli; Hector R Wong
Journal:  FASEB J       Date:  2016-07-19       Impact factor: 5.191

2.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

3.  Is Matrix Metalloproteinase-8 Activity in the Mucosal Barrier a Requirement for Leakage of Cecal Material in Peritonitis?

Authors:  Geert W Schmid-Schönbein
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

4.  Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model.

Authors:  Sarah J Atkinson; Brian M Varisco; Mary Sandquist; Meghan N Daly; Lindsey Klingbeil; Joshua W Kuethe; Emily F Midura; Kelli Harmon; Amy Opaka; Patrick Lahni; Giovanna Piraino; Paul Hake; Basilia Zingarelli; Joel E Mortenson; James L Wynn; Hector R Wong
Journal:  Mol Med       Date:  2016-08-08       Impact factor: 6.354

5.  Zinc supplementation leads to immune modulation and improved survival in a juvenile model of murine sepsis.

Authors:  Hammad A Ganatra; Brian M Varisco; Kelli Harmon; Patrick Lahni; Amy Opoka; Hector R Wong
Journal:  Innate Immun       Date:  2016-11-30       Impact factor: 2.680

6.  Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W Hart; Christopher J Lindsell
Journal:  EBioMedicine       Date:  2015-11-22       Impact factor: 8.143

Review 7.  The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.

Authors:  Gregg B Fields
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

8.  Recent advances in novel diagnostic testing for peritoneal dialysis-related peritonitis.

Authors:  Winston Wing-Shing Fung; Philip Kam-Tao Li
Journal:  Kidney Res Clin Pract       Date:  2022-01-21

9.  Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice.

Authors:  Marcel Doerflinger; Jason Glab; Christina Nedeva; Irvin Jose; Ann Lin; Lorraine O'Reilly; Cody Allison; Marc Pellegrini; Richard S Hotchkiss; Hamsa Puthalakath
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.